<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39459420</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1648-9144</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>06</Day></PubDate></JournalIssue><Title>Medicina (Kaunas, Lithuania)</Title><ISOAbbreviation>Medicina (Kaunas)</ISOAbbreviation></Journal><ArticleTitle>Design of an Epitope-Based Vaccine Against MERS-CoV.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1632</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/medicina60101632</ELocationID><Abstract><AbstractText><i>Background and Objectives:</i> Middle East Respiratory Syndrome (MERS) is a viral respiratory illness caused by a coronavirus called Middle East respiratory syndrome. In the current study, immunoinformatics studies were applied to design an epitope-based vaccine construct against Middle East Respiratory Syndrome. <i>Materials and Methods:</i> In this study, epitopes base vaccine construct was designed against MERS using immunoinformatics approach. <i>Results:</i> In this approach, the targeted proteins were screened, and probable antigenic, non-allergenic, and good water-soluble epitopes were selected for vaccine construction. In vaccine construction, the selected epitopes were joined by GPGPG linkers, and a linear multi-epitope vaccine was constructed. The vaccine construct underwent a physiochemical property analysis. The 3D structure of the vaccine construct was predicted and subjected to refinement. After the refinement, the 3D model was subjected to a molecular docking analysis, TLRs (TLR-3 and TLR-9) were selected as receptors for vaccine construct, and the molecular docking analysis study determined that the vaccine construct has binding ability with the targeted receptor. <i>Conclusions:</i> The docking analysis also unveils that the vaccine construct can properly activate immune system against the target virus however experimental validation is needed to confirm the in silico findings further.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Almanaa</LastName><ForeName>Taghreed N</ForeName><Initials>TN</Initials><AffiliationInfo><Affiliation>Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Medicina (Kaunas)</MedlineTA><NlmUniqueID>9425208</NlmUniqueID><ISSNLinking>1010-660X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D065207" MajorTopicYN="Y">Middle East Respiratory Syndrome Coronavirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="Y">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="Y">Viral Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="Y">Epitopes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Middle East Respiratory Syndrome (MERS)</Keyword><Keyword MajorTopicYN="N">epitope vaccine</Keyword><Keyword MajorTopicYN="N">molecular docking</Keyword><Keyword MajorTopicYN="N">molecular dynamic simulation</Keyword></KeywordList><CoiStatement>The author declares no conflict of interest. </CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39459420</ArticleId><ArticleId IdType="pmc">PMC11509718</ArticleId><ArticleId IdType="doi">10.3390/medicina60101632</ArticleId><ArticleId IdType="pii">medicina60101632</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gastanaduy P.A. Update: Severe respiratory illness associated with Middle East respiratory syndrome coronavirus (MERS-CoV)—Worldwide, 2012–2013. Morb. Mortal. Wkly. Rep. 2013;62:480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4604848</ArticleId><ArticleId IdType="pubmed">23760190</ArticleId></ArticleIdList></Reference><Reference><Citation>Azhar E.I., Hui D.S.C., Memish Z.A., Drosten C., Zumla A. The middle east respiratory syndrome (MERS) Infect. Dis. Clin. 2019;33:891–905. doi: 10.1016/j.idc.2019.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idc.2019.08.001</ArticleId><ArticleId IdType="pmc">PMC7127753</ArticleId><ArticleId IdType="pubmed">31668197</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams H.A., Dunville R.L., Gerber S.I., Erdman D.D., Pesik N., Kuhar D., Mason K.A., Haynes L., Rotz L., St. Pierre J. CDC’s early response to a novel viral disease, middle east respiratory syndrome coronavirus (MERS-CoV), September 2012–May 2014. Public Health Rep. 2015;130:307–317. doi: 10.1177/003335491513000407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/003335491513000407</ArticleId><ArticleId IdType="pmc">PMC4547580</ArticleId><ArticleId IdType="pubmed">26345122</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramadan N., Shaib H. Middle East respiratory syndrome coronavirus (MERS-CoV): A review. Germs. 2019;9:35. doi: 10.18683/germs.2019.1155.</Citation><ArticleIdList><ArticleId IdType="doi">10.18683/germs.2019.1155</ArticleId><ArticleId IdType="pmc">PMC6446491</ArticleId><ArticleId IdType="pubmed">31119115</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldenthal K.L., Midthun K., Zoon K.C. Control of Viral Infections and Diseases. University of Texas Medical Branch at Galveston; Galveston, TX, USA: 2011.</Citation><ArticleIdList><ArticleId IdType="pubmed">21413344</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharjee M., Banerjee M., Mukherjee A. In silico designing of a novel polyvalent multi-subunit peptide vaccine leveraging cross-immunity against human visceral and cutaneous leishmaniasis: An immunoinformatics-based approach. J. Mol. Model. 2023;29:99. doi: 10.1007/s00894-023-05503-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00894-023-05503-w</ArticleId><ArticleId IdType="pmc">PMC10018593</ArticleId><ArticleId IdType="pubmed">36928431</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham Peele K., Srihansa T., Krupanidhi S., Ayyagari V.S., Venkateswarulu T.C. Design of multi-epitope vaccine candidate against SARS-CoV-2: A in-silico study. J. Biomol. Struct. Dyn. 2021;39:3793–3801. doi: 10.1080/07391102.2020.1770127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2020.1770127</ArticleId><ArticleId IdType="pmc">PMC7284139</ArticleId><ArticleId IdType="pubmed">32419646</ArticleId></ArticleIdList></Reference><Reference><Citation>Gul S., Ahmad S., Ullah A., Ismail S., Khurram M., Tahir ul Qamar M., Hakami A.R., Alkhathami A.G., Alrumaihi F., Allemailem K.S. Designing a Recombinant Vaccine against Providencia rettgeri Using Immunoinformatics Approach. Vaccines. 2022;10:189. doi: 10.3390/vaccines10020189.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10020189</ArticleId><ArticleId IdType="pmc">PMC8876559</ArticleId><ArticleId IdType="pubmed">35214648</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshammari A., Alasmari A.F., Alharbi M., Ali N., Muhseen Z.T., Ashfaq U.A., Ud-Din M., Ullah A., Arshad M., Ahmad S. Novel Chimeric Vaccine Candidate Development against Leptotrichia buccalis. Int. J. Environ. Res. Public. Health. 2022;19:10742. doi: 10.3390/ijerph191710742.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191710742</ArticleId><ArticleId IdType="pmc">PMC9518150</ArticleId><ArticleId IdType="pubmed">36078462</ArticleId></ArticleIdList></Reference><Reference><Citation>Ud-Din M., Albutti A., Ullah A., Ismail S., Ahmad S., Naz A., Khurram M., Haq M.U., Afsheen Z., Bakri Y.E., et al. Vaccinomics to Design a Multi-Epitopes Vaccine for Acinetobacter baumannii. Int. J. Environ. Res. Public. Health. 2022;19:5568. doi: 10.3390/ijerph19095568.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19095568</ArticleId><ArticleId IdType="pmc">PMC9104312</ArticleId><ArticleId IdType="pubmed">35564967</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutet E., Lieberherr D., Tognolli M., Schneider M., Bansal P., Bridge A.J., Poux S., Bougueleret L., Xenarios I. UniProtKB/Swiss-Prot, the manually annotated section of the UniProt KnowledgeBase: How to use the entry view. Plant Bioinform. Methods Protoc. 2016;1374:23–54.</Citation><ArticleIdList><ArticleId IdType="pubmed">26519399</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhanda S.K., Mahajan S., Paul S., Yan Z., Kim H., Jespersen M.C., Jurtz V., Andreatta M., Greenbaum J.A., Marcatili P. IEDB-AR: Immune epitope database—Analysis resource in 2019. Nucleic Acids Res. 2019;47:W502–W506. doi: 10.1093/nar/gkz452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz452</ArticleId><ArticleId IdType="pmc">PMC6602498</ArticleId><ArticleId IdType="pubmed">31114900</ArticleId></ArticleIdList></Reference><Reference><Citation>Vita R., Mahajan S., Overton J.A., Dhanda S.K., Martini S., Cantrell J.R., Wheeler D.K., Sette A., Peters B. The immune epitope database (IEDB): 2018 update. Nucleic Acids Res. 2019;47:D339–D343. doi: 10.1093/nar/gky1006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1006</ArticleId><ArticleId IdType="pmc">PMC6324067</ArticleId><ArticleId IdType="pubmed">30357391</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackwell J.M., Jamieson S.E., Burgner D. HLA and infectious diseases. Clin. Microbiol. Rev. 2009;22:370–385. doi: 10.1128/CMR.00048-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00048-08</ArticleId><ArticleId IdType="pmc">PMC2668228</ArticleId><ArticleId IdType="pubmed">19366919</ArticleId></ArticleIdList></Reference><Reference><Citation>Doytchinova I.A., Flower D.R. VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform. 2007;8:4. doi: 10.1186/1471-2105-8-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-8-4</ArticleId><ArticleId IdType="pmc">PMC1780059</ArticleId><ArticleId IdType="pubmed">17207271</ArticleId></ArticleIdList></Reference><Reference><Citation>Rida T., Ahmad S., Ullah A., Ismail S., Tahir ul Qamar M., Afsheen Z., Khurram M., Saqib Ishaq M., Alkhathami A.G., Alatawi E.A. Pan-Genome Analysis of Oral Bacterial Pathogens to Predict a Potential Novel Multi-Epitopes Vaccine Candidate. Int. J. Environ. Res. Public. Health. 2022;19:8408. doi: 10.3390/ijerph19148408.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19148408</ArticleId><ArticleId IdType="pmc">PMC9320593</ArticleId><ArticleId IdType="pubmed">35886259</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullah A., Rehman B., Khan S., Almanaa T.N., Waheed Y., Hassan M., Naz T., ul Haq M., Muhammad R., Sanami S. An In Silico Multi-epitopes Vaccine Ensemble and Characterization Against Nosocomial Proteus penneri. Mol. Biotechnol. 2023:1–16. doi: 10.1007/s12033-023-00949-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12033-023-00949-y</ArticleId><ArticleId IdType="pubmed">37934390</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullah A., ul Haq M., Iqbal M., Irfan M., Khan S., Muhammad R., Ullah A., Khurram M., Alharbi M., Alasmari A.F. A computational quest for identifying potential vaccine candidates against Moraxella lacunata: A multi-pronged approach. J. Biomol. Struct. Dyn. 2024;42:2976–2989. doi: 10.1080/07391102.2023.2212793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2023.2212793</ArticleId><ArticleId IdType="pubmed">37177816</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimitrov I., Flower D.R., Doytchinova I. AllerTOP-a server for in silico prediction of allergens. BMC Bioinform. 2013;14:S4. doi: 10.1186/1471-2105-14-S6-S4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-S6-S4</ArticleId><ArticleId IdType="pmc">PMC3633022</ArticleId><ArticleId IdType="pubmed">23735058</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma N., Naorem L.D., Jain S., Raghava G.P.S. ToxinPred2: An improved method for predicting toxicity of proteins. Brief Bioinform. 2022;23:bbac174. doi: 10.1093/bib/bbac174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbac174</ArticleId><ArticleId IdType="pubmed">35595541</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas G., Zafar I., Ahmad S., Azam S.S. Staphylococcus hominis native mitral valve bacterial endocarditis (SBE) in a patient with hypertrophic obstructive cardiomyopathy. Heart Lung. 2007;36:380–382. doi: 10.1016/j.ejps.2019.105160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejps.2019.105160</ArticleId><ArticleId IdType="pubmed">17845885</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik M., Khan S., Ullah A., Hassan M., Ahmad S., Al-Harbi A.I., Sanami S., Abideen S.A., Irfan M., Khurram M. Proteome-wide Screening of Potential Vaccine Targets against Brucella melitensis. Vaccines. 2023;11:263. doi: 10.3390/vaccines11020263.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11020263</ArticleId><ArticleId IdType="pmc">PMC9966016</ArticleId><ArticleId IdType="pubmed">36851141</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlake T., Thess A., Fotin-Mleczek M., Kallen K.-J. Developing mRNA-vaccine technologies. RNA Biol. 2012;9:1319–1330. doi: 10.4161/rna.22269.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rna.22269</ArticleId><ArticleId IdType="pmc">PMC3597572</ArticleId><ArticleId IdType="pubmed">23064118</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo L., Park H., Seok C. GalaxyRefine: Protein structure refinement driven by side-chain repacking. Nucleic Acids Res. 2013;41:W384–W388. doi: 10.1093/nar/gkt458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt458</ArticleId><ArticleId IdType="pmc">PMC3692086</ArticleId><ArticleId IdType="pubmed">23737448</ArticleId></ArticleIdList></Reference><Reference><Citation>Bibi S., Ullah I., Zhu B., Adnan M., Liaqat R., Kong W.B., Niu S. In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology. Sci. Rep. 2021;11:1149. doi: 10.1038/s41598-020-80899-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-80899-6</ArticleId><ArticleId IdType="pmc">PMC7807040</ArticleId><ArticleId IdType="pubmed">33441913</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaydari A., Nazifi N., Forouharmehr A. Computational design of a novel multi-epitope vaccine against Coxiella burnetii. Hum. Immunol. 2020;81:596–605. doi: 10.1016/j.humimm.2020.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2020.05.010</ArticleId><ArticleId IdType="pubmed">32718721</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapin N., Lund O., Castiglione F. C-Immsim 10.1 server. PLoS Pathog. 2012;8:293</Citation></Reference><Reference><Citation>Ahmad S., Waheed Y., Ismail S., Abbasi S.W., Najmi M.H. A computational study to disclose potential drugs and vaccine ensemble for COVID-19 conundrum. J. Mol. Liq. 2021;324:114734. doi: 10.1016/j.molliq.2020.114734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molliq.2020.114734</ArticleId><ArticleId IdType="pmc">PMC7654302</ArticleId><ArticleId IdType="pubmed">33199930</ArticleId></ArticleIdList></Reference><Reference><Citation>Asad Y., Ahmad S., Rungrotmongkol T., Ranaghan K.E., Azam S.S. Immuno-informatics driven proteome-wide investigation revealed novel peptide-based vaccine targets against emerging multiple drug resistant Providencia stuartii. J. Mol. Graph. Model. 2018;80:238–250. doi: 10.1016/j.jmgm.2018.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmgm.2018.01.010</ArticleId><ArticleId IdType="pubmed">29414043</ArticleId></ArticleIdList></Reference><Reference><Citation>Reginald K., Chan Y., Plebanski M., Poh C.L. Development of peptide vaccines in dengue. Curr. Pharm. Des. 2018;24:1157–1173. doi: 10.2174/1381612823666170913163904.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612823666170913163904</ArticleId><ArticleId IdType="pmc">PMC6040172</ArticleId><ArticleId IdType="pubmed">28914200</ArticleId></ArticleIdList></Reference><Reference><Citation>Maleki A., Russo G., Parasiliti Palumbo G.A., Pappalardo F. In silico design of recombinant multi-epitope vaccine against influenza A virus. BMC Bioinform. 2021;22:617. doi: 10.1186/s12859-022-04581-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-022-04581-6</ArticleId><ArticleId IdType="pmc">PMC8808469</ArticleId><ArticleId IdType="pubmed">35109785</ArticleId></ArticleIdList></Reference><Reference><Citation>Devi A., Chaitanya N.S.N. In silico designing of multi-epitope vaccine construct against human coronavirus infections. J. Biomol. Struct. Dyn. 2021;39:6903–6917. doi: 10.1080/07391102.2020.1804460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2020.1804460</ArticleId><ArticleId IdType="pmc">PMC7484569</ArticleId><ArticleId IdType="pubmed">32772892</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai R., Ueda H., Kitayama A., Kamiya N., Nagamune T. Design of the linkers which effectively separate domains of a bifunctional fusion protein. Protein Eng. 2001;14:529–532. doi: 10.1093/protein/14.8.529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/protein/14.8.529</ArticleId><ArticleId IdType="pubmed">11579220</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullah A., Shahid F.A., Haq M.U., Tahir ul Qamar M., Irfan M., Shaker B., Ahmad S., Alrumaihi F., Allemailem K.S., Almatroudi A. An integrative reverse vaccinology, immunoinformatic, docking and simulation approaches towards designing of multi-epitopes based vaccine against monkeypox virus. J. Biomol. Struct. Dyn. 2023;41:7821–7834. doi: 10.1080/07391102.2022.2125441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2022.2125441</ArticleId><ArticleId IdType="pmc">PMC9527787</ArticleId><ArticleId IdType="pubmed">36129135</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshammari A., Alharbi M., Alghamdi A., Alharbi S.A., Ashfaq U.A., Tahir ul Qamar M., Ullah A., Irfan M., Khan A., Ahmad S. Computer-Aided Multi-Epitope Vaccine Design against Enterobacter xiangfangensis. Int. J. Environ. Res. Public. Health. 2022;19:7723. doi: 10.3390/ijerph19137723.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19137723</ArticleId><ArticleId IdType="pmc">PMC9265868</ArticleId><ArticleId IdType="pubmed">35805383</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S., Irfan M., Hameed A.R., Ullah A., Abideen S.A., Ahmad S., Haq M.U., El Bakri Y., Al-Harbi A.I., Ali M. Vaccinomics to design a multi-epitope-based vaccine against monkeypox virus using surface-associated proteins. J. Biomol. Struct. Dyn. 2023;41:10859–10868. doi: 10.1080/07391102.2022.2158942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2022.2158942</ArticleId><ArticleId IdType="pubmed">36533379</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig D.B., Dombkowski A.A. Disulfide by Design 2.0: A web-based tool for disulfide engineering in proteins. BMC Bioinform. 2013;14:346. doi: 10.1186/1471-2105-14-346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-346</ArticleId><ArticleId IdType="pmc">PMC3898251</ArticleId><ArticleId IdType="pubmed">24289175</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousaf M., Ullah A., Sarosh N., Abbasi S.W., Ismail S., Bibi S., Hasan M.M., Albadrani G.M., Talaat Nouh N.A., Abdulhakim J.A. Design of Multi-Epitope Vaccine for Staphylococcus saprophyticus: Pan-Genome and Reverse Vaccinology Approach. Vaccines. 2022;10:1192. doi: 10.3390/vaccines10081192.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10081192</ArticleId><ArticleId IdType="pmc">PMC9414393</ArticleId><ArticleId IdType="pubmed">36016080</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousaf M., Ismail S., Ullah A., Bibi S. Immuno-informatics profiling of monkeypox virus cell surface binding protein for designing a next generation multi-valent peptide-based vaccine. Front. Immunol. 2022;13:1035924. doi: 10.3389/fimmu.2022.1035924.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1035924</ArticleId><ArticleId IdType="pmc">PMC9668073</ArticleId><ArticleId IdType="pubmed">36405737</ArticleId></ArticleIdList></Reference><Reference><Citation>Marongiu L., Gornati L., Artuso I., Zanoni I., Granucci F. Below the surface: The inner lives of TLR4 and TLR9. J. Leukoc. Biol. 2019;106:147–160. doi: 10.1002/JLB.3MIR1218-483RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3MIR1218-483RR</ArticleId><ArticleId IdType="pmc">PMC6597292</ArticleId><ArticleId IdType="pubmed">30900780</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh H., Jakhar R., Sehrawat N. Designing spike protein (S-Protein) based multi-epitope peptide vaccine against SARS COVID-19 by immunoinformatics. Heliyon. 2020;6:e05528. doi: 10.1016/j.heliyon.2020.e05528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2020.e05528</ArticleId><ArticleId IdType="pmc">PMC7667438</ArticleId><ArticleId IdType="pubmed">33225084</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>